Literature DB >> 21987597

Randomization-Based Inference within Principal Strata.

Tracy L Nolen1, Michael G Hudgens.   

Abstract

In randomized studies, treatment comparisons conditional on intermediate post-randomization outcomes using standard analytic methods do not have a causal interpretation. An alternate approach entails treatment comparisons within principal strata defined by the potential outcomes for the intermediate outcome that would be observed under each treatment assignment. In this paper, we develop methods for randomization-based inference within principal strata. The proposed methods are compared with existing large-sample methods as well as traditional intent-to-treat approaches. This research is motivated by HIV prevention studies where few infections are expected and inference is desired within the always-infected principal stratum, i.e., all individuals who would become infected regardless of randomization assignment.

Entities:  

Year:  2011        PMID: 21987597      PMCID: PMC3188760          DOI: 10.1198/jasa.2011.tm10356

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  27 in total

1.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trial.

Authors:  Devan V Mehrotra; Xiaoming Li; Peter B Gilbert
Journal:  Biometrics       Date:  2006-09       Impact factor: 2.571

3.  On estimation of vaccine efficacy using validation samples with selection bias.

Authors:  Daniel O Scharfstein; M Elizabeth Halloran; Haitao Chu; Michael J Daniels
Journal:  Biostatistics       Date:  2006-03-23       Impact factor: 5.899

4.  Significance tests for 2 X 2 tables.

Authors:  G A BARNARD
Journal:  Biometrika       Date:  1947       Impact factor: 2.445

5.  An analytic method for randomized trials with informative censoring: Part 1.

Authors:  J M Robins
Journal:  Lifetime Data Anal       Date:  1995       Impact factor: 1.588

6.  Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.

Authors:  Charles S Chasela; Michael G Hudgens; Denise J Jamieson; Dumbani Kayira; Mina C Hosseinipour; Athena P Kourtis; Francis Martinson; Gerald Tegha; Rodney J Knight; Yusuf I Ahmed; Deborah D Kamwendo; Irving F Hoffman; Sascha R Ellington; Zebrone Kacheche; Alice Soko; Jeffrey B Wiener; Susan A Fiscus; Peter Kazembe; Innocent A Mofolo; Maggie Chigwenembe; Dorothy S Sichali; Charles M van der Horst
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

7.  On the analysis of viral load endpoints in HIV vaccine trials.

Authors:  Michael G Hudgens; Antje Hoering; Steven G Self
Journal:  Stat Med       Date:  2003-07-30       Impact factor: 2.373

8.  A comparison of methods for estimating the causal effect of a treatment in randomized clinical trials subject to noncompliance.

Authors:  Roderick J Little; Qi Long; Xihong Lin
Journal:  Biometrics       Date:  2008-05-28       Impact factor: 2.571

9.  Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected Postrandomization.

Authors:  Bryan E Shepherd; Peter B Gilbert; Thomas Lumley
Journal:  J Am Stat Assoc       Date:  2007-06       Impact factor: 5.033

10.  Causal inference in infectious diseases.

Authors:  M E Halloran; C J Struchiner
Journal:  Epidemiology       Date:  1995-03       Impact factor: 4.822

View more
  6 in total

1.  A causal framework for classical statistical estimands in failure-time settings with competing events.

Authors:  Jessica G Young; Mats J Stensrud; Eric J Tchetgen Tchetgen; Miguel A Hernán
Journal:  Stat Med       Date:  2020-01-27       Impact factor: 2.373

2.  A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomes.

Authors:  Jincheng Zhou; Haitao Chu; Michael G Hudgens; M Elizabeth Halloran
Journal:  Stat Med       Date:  2015-07-20       Impact factor: 2.373

3.  Methodological issues in the design and analyses of neonatal research studies: Experience of the NICHD Neonatal Research Network.

Authors:  Abhik Das; Jon Tyson; Claudia Pedroza; Barbara Schmidt; Marie Gantz; Dennis Wallace; William E Truog; Rosemary D Higgins
Journal:  Semin Perinatol       Date:  2016-06-22       Impact factor: 3.300

4.  Sharpening bounds on principal effects with covariates.

Authors:  Dustin M Long; Michael G Hudgens
Journal:  Biometrics       Date:  2013-11-18       Impact factor: 2.571

Review 5.  Statistical methods and graphical displays of quality of life with survival outcomes in oncology clinical trials for supporting the estimand framework.

Authors:  Kentaro Sakamaki; Takuya Kawahara
Journal:  BMC Med Res Methodol       Date:  2022-10-04       Impact factor: 4.612

6.  Identification and estimation of survivor average causal effects.

Authors:  Eric J Tchetgen Tchetgen
Journal:  Stat Med       Date:  2014-05-29       Impact factor: 2.373

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.